Open access
Open access
Powered by Google Translator Translator

Value-based Care

American Society of Health-System Pharmacists – Five Things Physicians and Patients Should Question

16 Jun, 2017 | 00:59h | UTC

New Choosing Wisely List: American Society of Health-System Pharmacists – Five Things Physicians and Patients Should Question (free)

See more on the Choosing Wisely initiative in our April 5 issue, see #6.

“Great choosing wisely list from @ASHPOfficial. Great doctoring tips for physicians & trainees” (RT @AnilMakam see Tweet)

 


Too much medical care: bad for you, bad for health care systems

16 Jun, 2017 | 00:54h | UTC

Opinion: Too much medical care: bad for you, bad for health care systems – STAT News (free)

 


Hospitals Are Dramatically Overpaying for Their Technology

15 Jun, 2017 | 00:49h | UTC

Hospitals Are Dramatically Overpaying for Their Technology – Harvard Business Review (a few articles per month are free)

“For years, hospitals have invested in sophisticated devices and IT systems that, on their own, can be awe-inspiring. Yet these technologies rarely share data, let alone leverage it to support better clinical care”.

 


Palliative care: A pathway to value-based care for nursing homes

12 Jun, 2017 | 19:56h | UTC

Palliative care: A pathway to value-based care for nursing homes – Diane E. Meier, M.D via McKnight (free)

 


Leading Quality in Changing Times

11 Jun, 2017 | 19:36h | UTC

Leading Quality in Changing Times – NEJM Catalyst (free)

“4 principles for quality leaders in brave new world of population health” (RT @nejmcatalyst see Tweet)

 


Value-based drug pricing makes sense, but is difficult to pull off

8 Jun, 2017 | 15:43h | UTC

Opinion: Value-based drug pricing makes sense, but is difficult to pull off – STAT News (free)

 


Can Personalized Care Planning Improve Primary Care?

8 Jun, 2017 | 15:45h | UTC

Viewpoint: Can Personalized Care Planning Improve Primary Care? – JAMA (free)

Related: Multimorbidity: clinical assessment and management – NICE Guideline (free)

See more on caring for people with Complex Needs in our April 24th issue (see #4),

 


Small wearable devices may lead to big health care savings

8 Jun, 2017 | 15:46h | UTC

Small wearable devices may lead to big health care savings – STAT News (free)

 


WHO updates Essential Medicines List

7 Jun, 2017 | 15:26h | UTC

News release: WHO updates Essential Medicines List with new advice on use of antibiotics, and adds medicines for hepatitis C, HIV, tuberculosis and cancer (free)

Report 1: The 2017 Expert Committee on the Selection and Use of Essential Medicines (free PDF)

Report 2: WHO Model List of Essential Medicines (free PDF)

Report 3: WHO Model List of Essential Medicines for Children (free PDF)

Commentaries: WHO creates controversial ‘reserve’ list of antibiotics for superbug threats – The Washington Post (free) AND Health officials set to release a list of drugs everyone on Earth should be able to access – STAT News (free) AND WHO’s New Essential Medicines List Includes a 40-Year First – Medscape (free registration required)

WHO Essential Medicines List is used by many countries to guide decisions regarding which medications should be available for their population.

 


#ASCO2017 – Small studies get big headlines

7 Jun, 2017 | 15:12h | UTC

#ASCO2017 – Small studies get big headlines at ASCO 2017 – HealthNewsReview (free)

“Claim – Biggest breakthrough in a decade”. “Reality – The trial included only 15 women; no survival outcomes measured” (RT @HealthNewsRevu see Tweet)

 


#ASCO2017 – Biosimilar May Be As Effective as Trastuzumab for Early Breast Cancer

7 Jun, 2017 | 15:13h | UTC

#ASCO2017 – CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Biosimilar May Be As Effective as Trastuzumab for Early Breast Cancer – Physician’s First Watch (free)

 


The Specialists’ Stranglehold on Medicine

7 Jun, 2017 | 15:04h | UTC

The Specialists’ Stranglehold on Medicine – The New York Times (10 articles per month are free)

 


#ASCO2017 – Survival in a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Cancer Treatment

5 Jun, 2017 | 14:52h | UTC

#ASCO2017 – Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment – JAMA (free)

Commentaries: Quickly reporting cancer complications may boost survival – STAT News (free) AND If This Were a Drug, the Price Would Be $100,000 – Medscape (free registration required) AND How a simple tech tool can help cancer patients live longer – The Washington Post (free)

“For surveillance of cancer, digital tracking of patient-generated data improves survival”. “The cost of digital tracking is very low and > 5 months median survival improvement is more than cancer drugs that cost > $100,000” (RT @EricTopol see Tweets and Answers)

 


Engaging Patients in Patient Safety – a Canadian Guide

5 Jun, 2017 | 14:49h | UTC

Engaging Patients in Patient Safety – a Canadian Guide (free) (RT @pash22)

News release: How to Effectively Engage Patients in Patient Safety: New Guide available (free)

 


The Value of Teaching Patients to Administer Their Own Care

5 Jun, 2017 | 14:45h | UTC

The Value of Teaching Patients to Administer Their Own Care – Harvard Business Review (a few articles per month are free) (RT @EricTopol see Tweet)

 


Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care

4 Jun, 2017 | 19:16h | UTC

Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care – JAMA Oncology (link to abstract – $ for full-text)

Commentary: ‘Bundled’ Payments Beat Fee-for-Service: Cost, quality of care, and survival rates all better – MedPage Today (free registration required)

Related: Value-Based Care in the Worldwide Battle Against Cancer – Cureus (free)

 


Cancer drugs are getting better and dearer

1 Jun, 2017 | 18:27h | UTC

Cancer drugs are getting better and dearer – The Economist (a few articles per month are free) (RT @pash22 see Tweet)

See more articles and commentaries about “financial toxicity” of cancer treatments in our April 27 issue, see #8.

 


Diagnosis creep: the new problem in medicine

30 May, 2017 | 15:30h | UTC

Diagnosis creep: the new problem in medicine – MJA Insight (free)

Related: How to rein in the widening disease definitions that label more healthy people as sick – The Conversation (free)

 


Direct-to-Consumer Medical Testing in the Era of Value-Based Care

29 May, 2017 | 15:24h | UTC

Viewpoint: Direct-to-Consumer Medical Testing in the Era of Value-Based Care – JAMA (free)

See also a recent discussion on direct-to-consumer genetic testing in our April 10th issue, see #5

Others disagree: “Dissing every consumer medical test as “low value”. Sorry, that’s not true. It’s called paternalism” (RT @EricTopol see Tweet)

 


Recent articles on payment models published in JAMA

26 May, 2017 | 15:05h | UTC

Recent articles on payment models published in JAMA

The Next Generation of Episode-Based Payments – JAMA (free) AND Value-Based Payment Models for Community Health Centers: Time to (Cautiously) Take the Plunge? – JAMA (free) AND Business Model–Related Conflict of Interests in Medicine: Problems and Potential Solutions – JAMA (free)

 


Effect of a Modified Hospital Elder Life Program on Delirium and Length of Hospital Stay in Patients Undergoing Abdominal Surgery

25 May, 2017 | 14:50h | UTC

Effect of a Modified Hospital Elder Life Program on Delirium and Length of Hospital Stay in Patients Undergoing Abdominal Surgery: A Cluster Randomized Clinical Trial – JAMA Surgery (free) (RT @PreetiNMalani see Tweet)

Commentary: Anti-delirium strategy reduces after-surgery confusion in elderly – Reuters Health (free)

Multicomponent nonpharmacologic interventions, including orienting communications, oral and nutritional assistance, and early mobilization reduced postoperative delirium by 56% and length of stay by 2 days.

 


Reoperation and Medicare Expenditures After Laparoscopic Gastric Band Surgery

23 May, 2017 | 14:25h | UTC

Reoperation and Medicare Expenditures After Laparoscopic Gastric Band Surgery – JAMA Surgery (link to abstract – $ for full-text)

Commentaries: Following gastric band surgery, device-related reoperation common, costly – Science Daily (free) AND Safety, Effectiveness of Gastric Banding Called Into Question – Medscape (free registration required) AND 1 In 5 Gastric Band Surgeries Require Corrective Operations – American Council on Science and Health (free)

 


How to rein in the widening disease definitions that label more healthy people as sick

17 May, 2017 | 20:19h | UTC

Viewpoint: How to rein in the widening disease definitions that label more healthy people as sick – The Conversation (free)

 


Switching to biosimilar

16 May, 2017 | 20:01h | UTC

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial – The Lancet (link to abstract – $ for full-text)

Commentary: Celltrion Healthcare: Lancet Publishes Full Data-Set from Influential NOR-SWITCH Study – Business Wire (free)

 


Measuring the Burden of Medications in Older Adults near the End of Life

16 May, 2017 | 20:00h | UTC

Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study – The American Journal of Medicine (free)

See related study on the use of Medications of Questionable Benefit at the End of Life in our April 10th issue, see #8 and Deprescribing guidelines for elderly in our May 8th issue, see #4.

Source: Patient often prescribed potentially futile drugs in their final months of life – Science Daily (free)

“Nearly half of older adults in Sweden take 10 or more medications in their last months of life” (from Science Daily)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.